Q1 2025 Vicarious Surgical Inc Earnings Call Transcript
Key Points
- Vicarious Surgical Inc (RBOT) is on track to become a clinical-stage company in 2025, marking a significant milestone in its development.
- The company successfully built its first patient card and surgeon console for pre-clinical testing, indicating progress in its product development.
- A new strategic partnership with UMass Memorial Medical Center aims to optimize the integration of their robotic system into hospital environments.
- Operating expenses decreased by 2% compared to the first quarter of 2024, demonstrating effective expense management.
- The company maintains a strong cash position with approximately $37 million in cash, cash equivalents, and short-term investments, supporting its operational needs.
- Vicarious Surgical Inc (RBOT) reported an adjusted net loss of $15.3 million for the first quarter of 2025, indicating ongoing financial challenges.
- The company anticipates a full-year 2025 cash burn of approximately $50 million, which may require additional financing.
- Supply chain complexities remain a concern, although the company has managed them effectively so far.
- The approval process for conducting first clinical procedures is ongoing, with potential delays if regulatory hurdles arise.
- The company is still in the pre-commercial stage, with revenue generation dependent on future product approvals and market adoption.
Hello, everyone, and welcome to the Vicarious Surgical's 2025 first-quarter earnings call. My name is Nadia and I'll be coordinating the call today. (Operator Instructions)
I will now hand over to your host, [Web Campbell], Investor Relations, to begin. Web, please go ahead.
Good afternoon. Today, aftermarket closed, Vicarious Surgical released financial results for the three months ended March 31, 2025. A copy of the press release is available on the company's website.
Before we begin, I'd like to remind you that management will make statements during this call that include forward-looking statements within the meaning of federal securities law, which are made pursuant to the Safe Harbor provision of the Private Securities Litigation Reform Act of 1995. Any statements contained in this call that relate to expectations or predictions of future events, results or performance are forward-looking statements.
All forward-looking statements, including without limitation, those
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
